Jingbo Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Chronic Kidney Disease

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

International journal of laboratory hematology

Leukemia & lymphoma

Cancer medicine

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Song Xue, Wenqiu Huang, Yongping Zhang, Fuhong Liu, Qi Hao, Jiajun Hu, Lei Yuan, Jingbo Wang
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation. International journal of laboratory hematology (2024)
Song Xue, Wenqiu Huang, Yongping Zhang, Fuhong Liu, Qi Hao, Jiajun Hu, Lei Yuan, Jingbo Wang
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation. International journal of laboratory hematology 46 (4) (2024)
Song Xue, Wenqiu Huang, Yongping Zhang, Fuhong Liu, Qi Hao, Jiajun Hu, Lei Yuan, Jingbo Wang
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation. International journal of laboratory hematology 46 (4) (2024)
Song Xue, Lili Miao, Zimu Gong, Wenqiu Huang, Yongping Zhang, Fuhong Liu, Jingbo Wang
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejection. Cancer innovation 2 (4) (2023)
Song Xue, Wenqiu Huang, Fuhong Liu, Yongping Zhang, Qi Hao, Bin Cui, Suning Chen, Jingbo Wang
Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and <i>KIT</i> mutation relapse post allo-HSCT. Leukemia & lymphoma 63 (9) (2022)
Xinhong Fei, Shuqin Zhang, Jiangying Gu, Jingbo Wang
FLT3 inhibitors as maintenance therapy post allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with FLT3 mutations: A meta-analysis. Cancer medicine (2022)
Qi Hao, Xinyue Liu, Yongping Zhang, Dongmei Zhang, Boran Li, Jingbo Wang
MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Journal of clinical laboratory analysis 35 (10) (2021)